Columbia Disposable Syringes Market Research Report, 2030

Colombia’s healthcare landscape, stretching from modern hospitals in Bogotá to small clinics in remote Andean villages and jungle outposts, has seen a remarkable transformation with the introduction and widespread adoption of disposable syringes. Prior to this shift, the majority of healthcare facilities used reusable glass syringes that required thorough sterilization after each use often through boiling or autoclaving methods. These practices, while intended to reduce infection risk, frequently suffered from inconsistent application, limited resources, and human error, especially in rural and underfunded areas. This created significant risks of spreading bloodborne diseases such as HIV/AIDS, hepatitis B, and hepatitis C. Recognizing this urgent public health issue, Colombian healthcare authorities and policymakers began advocating for disposable syringes during the late 1980s and early 1990s, coinciding with global movements to improve injection safety. Technically, a disposable syringe is a single-use, pre-sterilized device consisting of a clear plastic barrel, a tightly fitting plunger with a rubber seal, and a stainless steel needle. This design ensures sterility and prevents reuse, which is crucial for breaking the chain of infection. Disposable syringes in Colombia are used across a broad spectrum of settings, including national immunization campaigns, emergency care units, outpatient clinics, dental offices, veterinary practices, and increasingly in home care, especially for diabetic patients who require regular insulin injections. Local manufacturers, alongside international suppliers, provide a variety of syringes tailored to different clinical needs, including auto-disable syringes to prevent reuse in vaccination drives and safety syringes with retractable needles to reduce accidental needle-stick injuries among healthcare workers. Despite these advances, Colombia still faces significant challenges. The management of biomedical waste remains underdeveloped in many urban centers, leading to environmental hazards and health risks for waste collectors and the public. In rural and conflict-affected regions, harsh geography and security issues disrupt supply chains, causing syringe shortages that jeopardize patient safety. According to the research report "Colombia Disposable Syringe Market Research Report, 2030," published by Actual Market Research, the Colombia Disposable Syringe Market was valued at more than USD 30 Million in 2024. The government’s expansive immunization programs against diseases such as yellow fever, measles, influenza, and most recently, COVID-19, generate massive demand for disposable syringes. These campaigns reach millions of people across urban and remote rural settings, requiring large-scale, reliable syringe supplies that ensure safety and efficiency. Additionally, the growing prevalence of chronic diseases like diabetes and rheumatoid arthritis drives steady usage of syringes for administering insulin and other injectable medications on a daily basis, especially as access to home healthcare services improves. Recent developments include the entry of advanced syringe technologies into the market, such as safety syringes with retractable needles designed to minimize needle-stick injuries, and prefilled syringes that simplify vaccine administration and reduce dosing errors. Major players in Colombia’s syringe market include Tecnoquímicas, one of the country’s largest pharmaceutical companies, global giant Becton Dickinson, and Medimás, which focuses on providing affordable medical devices to public health programs and private clinics alike. These companies emphasize quality assurance, regulatory compliance, and extensive distribution networks to cover Colombia’s diverse geographic and socio-economic landscape. Opportunities in the market are significant: expanding healthcare access in underserved rural and conflict-affected regions offers a chance to increase syringe penetration and improve health outcomes, while rising demand for environmentally friendly and biodegradable syringe options aligns with growing public and governmental environmental awareness. Regulatory compliance under INVIMA ensures syringes meet strict sterility, safety, and quality standards, protecting patient health and preventing the infiltration of counterfeit or substandard devices. This regulatory framework builds trust among healthcare providers and consumers and supports Colombia’s health system modernization. Emerging trends include increased adoption of smart syringes equipped with digital tracking capabilities to enhance inventory management and prevent stockouts, wider use of prefilled syringes to speed up vaccination drives, and innovation in eco-friendly disposal systems designed to reduce biomedical waste impact. These trends show Colombia’s commitment to combining technological innovation, public health safety, and environmental sustainability as it continues to strengthen its disposable syringe market for the future.

What's Inside a Actual Market Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Colombia’s disposable syringe market is witnessing steady expansion and dynamic change as the nation seeks to strengthen its healthcare infrastructure and promote safer medical practices across diverse settings. Conventional syringes, typically constructed from basic plastic barrels and plungers with attached needles, remain prevalent especially in public hospitals, community clinics, and rural healthcare centers where budget constraints and resource limitations require cost-effective medical supplies. However, growing recognition of the dangers posed by needle reuse and accidental needle-stick injuries has driven heightened demand for safety syringes. These advanced devices feature built-in safety mechanisms such as retractable needles, protective needle shields, and auto-disable functions, effectively preventing reuse and minimizing occupational hazards for healthcare workers. The Colombian government, in alignment with global health guidelines, has actively promoted the adoption of safety syringes through regulatory frameworks and awareness campaigns aimed at reducing transmission of bloodborne infections like HIV and hepatitis B. This regulatory push has resulted in an accelerated uptake of safety syringes, particularly in urban hospitals, specialized clinics, and mass immunization campaigns. Nevertheless, conventional syringes continue to hold a significant market share in rural and under-resourced areas, highlighting an ongoing challenge to balance affordability with enhanced safety. This duality reflects Colombia’s evolving disposable syringe market as it gradually transitions towards safer technologies while ensuring broad accessibility in a country characterized by diverse socioeconomic conditions and healthcare disparities. Immunization injections represent a substantial portion of syringe consumption, fueled by large-scale vaccination programs targeting endemic and emerging diseases such as influenza, hepatitis B, human papillomavirus, and the recent COVID-19 pandemic response. These programs demand syringes that guarantee sterility, ease of use in mass campaigns, and integrated safety features to prevent reuse and cross-contamination, thereby protecting patients and healthcare providers while building community trust in immunization efforts. In parallel, therapeutic injections form a critical segment driven by the rising burden of chronic diseases such as diabetes, cancer, arthritis, and autoimmune disorders within Colombia’s population. Increasing adoption of prefilled syringes and ergonomically optimized injection devices in outpatient settings and home healthcare reflects a growing emphasis on patient convenience, accurate dosing, and minimizing the risk of injection-related infections. This shift supports self-administration trends and improved adherence to treatment regimens, which are essential for managing long-term health conditions. The widespread use of disposable syringes in both immunization and therapeutic contexts underscores their vital contribution to Colombia’s healthcare delivery, enabling safer, more effective, and patient-friendly injection practices across varied clinical environments. Hospitals remain the largest and most diverse consumers of disposable syringes, utilizing them for vaccination programs, surgical procedures, anesthesia delivery, emergency care, and general medical treatments where infection control and staff safety are paramount. High-quality syringes with advanced safety features are critical in these settings to reduce healthcare-associated infections and protect medical personnel from needle-stick injuries. Diagnostic laboratories also heavily depend on disposable syringes for the sterile collection of blood and other biological specimens, where sample integrity directly influences diagnostic accuracy and patient outcomes. Blood banks require syringes that adhere to strict sterility and safety standards to facilitate safe blood collection and transfusions, protecting both donors and recipients from contamination risks. The pharmaceutical industry is increasingly driving demand for prefilled syringes, which offer distinct advantages such as precise medication dosing, reduced preparation times, and enhanced patient safety features particularly valued in clinical trial settings and commercial drug delivery. Colombia’s growing pharmaceutical manufacturing and biotechnology sectors, supported by investments in healthcare innovation and research, further stimulate the adoption of advanced syringe technologies. These end users create a robust and multifaceted market landscape that demands ongoing improvements in disposable syringe safety, efficacy, and convenience, reflecting Colombia’s broader commitment to enhancing healthcare quality, accessibility, and patient care outcomes throughout the country.

Make this report your own

We're excited to discuss your needs and our solutions. Let's schedule a call.

Ask an Expert

Nikita Jabrela

Business Development Manager

Considered in this report • Historic Year: 2019 • Base year: 2024 • Estimated year: 2025 • Forecast year: 2030 Aspects covered in this report • Disposable Syringes Market with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Type • Conventional Syringes • Safety Syringes

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

By Application • Immunization Injections • Therapeutic Injections By End User • Hospitals • Diagnostic Laboratories • Blood Banks • Others (Pharmaceutical Industry (B2B) (Prefilled Syringes)) The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analyzing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to this industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.